Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Psychiatry. 1990 Oct;51 Suppl:18-21; discussion 29-32.

Anxiety in the elderly: treatment strategies.

Author information

1
Department of Psychiatry, Harvard Medical School, Massachusetts Mental Health Center, Boston 02115.

Abstract

Anxiety in the elderly is often mixed with depression, and successful antidepressant treatment will often also eliminate the anxiety. For specific symptoms of generalized anxiety, benzodiazepines are important therapeutic agents. Selection of an appropriate benzodiazepine is guided by pharmacokinetic properties of individual drugs. Long half-life benzodiazepines usually are not preferred for older patients because of cumulative toxicity. Among the short half-life drugs, high-potency compounds (e.g., lorazepam, alprazolam) may be more toxic than low-potency compounds (e.g., oxazepam). Although confirming controlled data are lacking, clinical experience suggests that dependence, rebound symptoms, and memory impairment may be more intense with lorazepam and alprazolam. Clinicians should endeavor to use benzodiazepines for short periods when treating the elderly. Long-term use has been reported effective and nonhazardous, but subtle and gradual cognitive impairment may occur in other patients over time. Buspirone has also been reported as an effective, nontoxic antianxiety compound for older patients, but more experience and comparative research data are needed.

PMID:
1976620
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center